Search Results
Jul 16, 2026, 09:00 ET Priority Health Collaborates With GRAIL as the First Michigan Health Plan to Offer the Galleri® Multi-Cancer Early Detection Blood Test to Employer Plans
cancers1. The Galleri test is the only MCED test clinically proven through a randomized controlled trial to increase earlier cancer detection (Stage I-III) and reduce Stage IV diagnoses - enabling more patients to have access to potentially curative treatment options2. When added to standard-of-care
More news about: GRAIL, Inc.
Jul 16, 2026, 09:00 ET Envestnet Introduces List of Interval Funds Approved by Manager Research Team
Public markets are a shrinking part of the US economy," Apollo Global Management, February 2026[iii] Cerulli Associates, Sept. 30, 2025. "Private Markets Retail Assets to Reach $3.7 Trillion Through 2029."
More news about: Envestnet
Jul 16, 2026, 09:00 ET Galaxy Launches Institutional Vault Curator
Act 2000 (Financial Promotion) Order 2005 as amended (the "FPO"); (ii) persons or entities of a kind described in article 49 of the FPO; and (iii) other persons to whom it may otherwise lawfully be communicated (all such persons together being referred to as "relevant persons"). This communication
More news about: Galaxy Digital Inc.
Jul 16, 2026, 08:30 ET Bitmine Immersion Technologies (BMNR) Releases July Chairman's Message: "ETH is the cure for the 'Uncanny Valley of Wealth'"
Bitmine remains supported by a premier group of institutional investors including ARK's Cathie Wood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital and personal investor Thomas "Tom" Lee to support Bitmine's goal of acquiring 5% of ETHNORWALK,
More news about: Bitmine Immersion Technologies, Inc.
Jul 16, 2026, 08:30 ET Bitmine Immersion Technologies (BMNR) Releases July Chairman's Message: "ETH is the cure for the 'Uncanny Valley of Wealth'"
Bitmine remains supported by a premier group of institutional investors including ARK's Cathie Wood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital and personal investor Thomas "Tom" Lee to support Bitmine's goal of acquiring 5% of ETH
More news about: Bitmine Immersion Technologies, Inc.
Jul 16, 2026, 08:14 ET Taylor Morrison Announces Consent Solicitations
U8760NAB5 (Reg S)) (the "2028 Notes"), (ii) its 5.125% Senior Notes due 2030 (CUSIP Nos. 87724RAJ1 (Rule 144A) / U8760NAF6 (Reg S)) (the "2030 Notes") and (iii) its 5.750% Senior Notes due 2032 (CUSIP Nos. 87724RAK8 (Rule 144A) / U8760NAG4 (Reg S)) (the "2032 Notes" and, together with the 2028 Notes and the
More news about: Taylor Morrison
Jul 16, 2026, 08:00 ET Prologis Reports Second Quarter 2026 Results
local economic and political climates and conditions; (ii) changes in global financial markets, interest rates and foreign currency exchange rates; (iii) increased or unanticipated competition for our properties; (iv) risks associated with acquisitions, dispositions and development of properties, including
More news about: Prologis, Inc.
Jul 16, 2026, 07:00 ET Standardizing Immune-Related AE Management in Global Oncology Trials, Upcoming Webinar Hosted by Xtalks
SVP, Head of Medical Affairs and Medical Oncology Strategy Lead; and Salini Naidu, MD, Senior Medical Director III, Medical Oncology and Oncology Strategy, Medical Affairs, for the live webinar on Tuesday, August 4, 2026, at 11am EDT (5pm CEST/EU-Central).
More news about: Xtalks
Jul 16, 2026, 07:00 ET Annonce d'un accord de distribution pour Zemcelpro® en Argentine, à Hong Kong et à Singapour
génétiques, les patients nécessitant une deuxième greffe, ainsi que les patients présentant une maladie réfractaire ou active. Un essai clinique de phase III déterminant sera lancé dès que possible auprès de cette population de patients.L'utilisation de Zemcelpro® chez d'autres populations
More news about: ExCellThera
Jul 16, 2026, 07:00 ET Main Street Announces Preliminary Estimate of Second Quarter 2026 Operating Results
not require settlement in cash, (ii) deferred compensation expense or benefit does not result in a net cash impact to Main Street upon settlement and (iii) tax expenses included in NII may include (a) excise tax expense, which is not solely attributable to NII, and (b) deferred taxes, which are not payable
More news about: Main Street Capital Corporation
Jul 16, 2026, 06:30 ET ORVANA REPORTS Q3 FY2026 PRODUCTION RESULTS AND PROVIDES UPDATE ON OXIDES STOCKPILE PROJECT AT DON MARIO, BOLIVIA
commissioning and ramp-up activities; (ii) no material disruptions to operations due to labour, supply chain, power, equipment damage or other events; (iii) permitting, development, operations and expansion activities at Orovalle, Don Mario and Taguas proceeding consistent with the Company's current expectations;
More news about: Orvana Minerals Corp.
Jul 16, 2026, 06:00 ET GPGI INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against GPGI, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit
track to achieve the revenue and Adjusted EBITDA targets provided in the proxy statement and such targets lacked a reasonable basis in objective fact; (iii) a primary motivation of the Husky Acquisition was to generate millions of dollars in fees for Resolute Holdings and the individual defendants, rather
More news about: Robbins Geller Rudman & Dowd LLP
Jul 16, 2026, 00:01 ET Zero Gap Fund's Catalytic Capital Keeps Multiplying: $30M Sustains $1.05B for the UN Sustainable Development Goals
include: LeapFrog's Emerging Consumer Fund III (Fund III) is a growth equity fund serving low-income consumers in Asia and Africa, incorporating a blended finance insurance product to mitigate tail-end risks. Fund III has supported more than 173,000 jobs and reached 361 million
More news about: The Rockefeller Foundation
Jul 15, 2026, 17:50 ET NextEra Energy and Dominion Energy file to combine, building a stronger company to meet growing power demand across four of America's fastest-growing states while keeping energy affordable and reliable
2025, which was filed with the SEC on February 13, 2026, including under the heading "Item 1. Business—Information About Our Executive Officers" and (iii) to the extent certain holdings of NextEra Energy securities by its directors or executive officers have changed since the amounts set forth in NextEra
More news about: NextEra Energy, Inc.; Dominion Energy
Jul 15, 2026, 16:11 ET /C O R R E C T I O N -- Honeywell Aerospace Inc./
principal amount of new 3.900% Senior Notes due 2028;(ii) $1,250,000,000 aggregate principal amount of new 4.000% Senior Notes due 2029;(iii) $500,000,000 aggregate principal amount of new Floating Rate Senior Notes due 2029;(iv) $2,000,000,000 aggregate principal amount of new 4.300%
More news about: Honeywell Aerospace Inc.
Jul 15, 2026, 15:55 ET NNS adquiere acciones en OCI
riesgos relacionados con la obtención de aprobaciones regulatorias sin demoras o condiciones imprevistas y la posibilidad de acciones regulatorias; (iii) riesgos relacionados con costes significativos relacionados con la transacción; (iv) el rendimiento financiero y operativo esperado y las oportunidades
More news about: NNS Holding (Cyprus) Limited
Jul 15, 2026, 15:36 ET Haute Jets and 5W AI Communications Release First Ranking of the 25 Private Aviation Corridors Carrying the World's UHNW Population
The Private Aviation Corridor Report 2026 — Volume III of the wealth-intelligence research series. The report indexes the 25 private aviation corridors carrying the world's ultra-high-net-worth (UHNW) population
More news about: 5W Public Relations
Jul 15, 2026, 14:02 ET NNS erwirbt Anteile an OCI
im Zusammenhang mit dem Erhalt behördlicher Genehmigungen ohne unerwartete Verzögerungen oder Auflagen sowie die Möglichkeit behördlicher Maßnahmen; (iii) Risiken im Zusammenhang mit erheblichen Kosten der Transaktion; (iv) die erwartete finanzielle und operative Entwicklung sowie zukünftige Chancen nach
More news about: NNS Holding (Cyprus) Limited
Jul 15, 2026, 13:56 ET NNS acquiert des actions d'OCI
risques liés à l'obtention des autorisations réglementaires sans retards ni conditions imprévus, ainsi que la possibilité de mesures réglementaires ; (iii) les risques liés aux coûts importants associés à l'opération ; (iv) les performances financières et opérationnelles attendues ainsi que les opportunités
More news about: NNS Holding (Cyprus) Limited
Jul 15, 2026, 13:18 ET NNS acquires shares in OCI
at all; (ii) risks relating to the receipt of regulatory approvals without unexpected delays or conditions and the possibility of regulatory action; (iii) risks relating to significant costs related to the transaction; (iv) the expected financial and operating performance and future opportunities following
More news about: NNS Holding (Cyprus) Limited
Jul 15, 2026, 13:15 ET NNS acquires shares in OCI
at all; (ii) risks relating to the receipt of regulatory approvals without unexpected delays or conditions and the possibility of regulatory action; (iii) risks relating to significant costs related to the transaction; (iv) the expected financial and operating performance and future opportunities following
More news about: NNS Holding (Cyprus) Limited
Jul 15, 2026, 11:56 ET POSCO announces the early tender results of its Offer to Purchase for cash up to US$400,000,000 aggregate principal amount of its outstanding 5.750% Notes due 2028
or eliminate the Maximum Acceptance Amount and, in each case, may do so without extending the Early Tender Deadline or the Withdrawal Deadline and (iii) otherwise amend or waive any of the terms and conditions of the Offer at any time, as described in the Offer to Purchase under the heading "Amendment
More news about: POSCO
Jul 15, 2026, 11:33 ET Azitra, Inc. Announces Breakthrough Repeat Dose and Anti-Wrinkle Ex Vivo Results for ATR-COSF Program, Demonstrating Increased Distribution and Elasticity
safety data and topline results for the Phase 1b trial for our ATR-12, (ii) the abstract detailing the Phase 1/2 clinical trial for our ATR-04 program, (iii) our provision of initial safety data and topline results for the Phase 1/2 clinical trial for our ATR-04 program, and (iv) statements about our clinical
More news about: Azitra, Inc.
Jul 15, 2026, 11:15 ET Global Data Center Market Investment to Reach USD 959.19 Billion by 2031- Exclusive Insight by Arizton
SecurityFire Detection & SuppressionDCIMTier StandardTier I & IITier IIITier IVSegmentation by GeographyNorth AmericaLatin AmericaWestern EuropeNordics,
More news about: Arizton Advisory & Intelligence
Jul 15, 2026, 10:31 ET Soft Tissue Sarcoma Market Set for Significant Growth at a CAGR of 7.9% During the Forecast Period (2026-2036), Driven by Novel Therapies and Expanding Treatment Landscape | DelveInsight
scientific advice with EMA and FDA to align on a new Phase III study of Fibromun in first-line STS; the new study is expected to start in 2026.In May 2026, PharmaMar reported completion of patient enrollment in the global Phase III SaLuDo trial evaluating ZEPZELCA (lurbinectedin) plus doxorubicin
More news about: DelveInsight Business Research, LLP